专利检索_..卤素或其化合物专利检索_..卤素或其化合物专利检索查询

序号	专利名	申请号	申请日	公开（公告）号	公开（公告）日	发明人
181	Vapor deposited metal catalytic film, process for making the same and liquid container with the film	US538570	1990-06-15	US5077258A	1991-12-31	Roger W. Phillips; Lauren R. Wendt
Metal catalytic film comprising a flexible substrate having a surface, a catalytic metal layer adherent to said surface of the substrate and having a thickness ranging from 200 to 1000 Angstroms.Method for forming metal catalytic film on a flexible substrate having a surface in a vacuum chamber comprising the steps of evacuating the vacuum chamber to a predetermined vacuum, introducing a substantially inert heavy gas into the vacuum chamber, creating a vapor stream of molecules of a catalytic metal in the vacuum chamber whereby the molecules of the catalytic metal are scattered by the inert heavy gas and are subsequently deposited upon the surface of the substrate to form a catalytic metal layer to a thickness ranging from 200 to 1000 Angstroms.
182	Method for cleaning dental prosthetic devices	US360422	1989-06-02	US4975285A	1990-12-04	Perry A. Ratcliff
The use of stabilized chlorine dioxide or chlorine dioxide in aqueous solution as a composition to reduce or prevent plaque formation and treatment of oral diseases ecologically plaque dependent, such as gingivitis and periodontitis, is disclosed. Preferred concentrations are in the range of 0.005% to 0.2% and the chlorine dioxide may be in the form of a rinse, a wash, a soak or a dentifrice.
183	Method for retarding dental plaque by killing streptococcus sanguis	US279360	1988-12-02	US4889714A	1989-12-26	Perry A. Ratcliff
The use of stabilized chlorine dioxide or chlorine dioxide in aqueous solution as a composition to reduce or prevent plaque formation and treatment of oral diseases ecologically plaque dependent, such as gingivitis and periodontitis, is disclosed. Preferred concentrations are in the range of 0.005% to 0.2% and the chlorine dioxide may be in the form of a rinse, a wash, a soak or a dentifrice.
184	Anti-microbial compositions comprising an aqueous solution of a germicidal polymeric nitrogen compound and a potentiating oxidizing agent	US700745	1985-02-12	US4654208A	1987-03-31	Richard F. Stockel; Murray Jelling
An anti-microbial composition comprises an aqueous solution of a germicidal polymeric nitrogen compound and an oxidizing agent which potentiates the activity of the compound. The polymeric nitrogen compound includes a germicidal quaternary ammonium compound or a polyguanide compound. The oxidizing agent has a standard reduction potential between 0.85 and 2.0 volts, is soluble in water, non-toxic and enhances the activity germicidal of the nitrogen polymer at low concentrations. Suitable oxidizing agents include halogen oxides, oxyhalogens, halogens, and inorganic and organic peroxides.
185	Anti-microbial compositions and associated methods for preparing the same and for the disinfecting of various objects	US471011	1983-03-01	US4499077A	1985-02-12	Richard F. Stockel; Murray Jelling
An anti-microbial composition is provided comprising an aqueous solution of an oxyhalogen compound and a polymeric germicide. The oxyhalogen compound is preferably stabilized chlorine dioxide and the polymeric germicide is preferably a quaternary ammonium compound such as a copolymer of at least one difunctional tertiary amine and a dihalo organic compound such as 1,4-dihalo-2-butene, a copolymer of at least one difunctional tertiary amine, at least one monofunctional tertiary amine and a dihalo organic compound such as 1,4-dihalo-2-butene, or a polyguanide such as hydrochloride salt of poly(hexamethylene biguanide). The anti-microbial composition thus formed is used for the treatment of soft contact lenses to disinfect the same with an optimum effect while minimizing the irritant possibilities thereof and also minimizing absorption of the composition into the porous and hydrophilic surfaces of soft contact lenses such that there is a minimal release of absorbed substances after treatment.
186	Aqueous solution suitable for dissipating available iodine contained in an iodophor	US582762	1975-06-02	US4031209A	1977-06-21	Joseph Zenon Krezanoski
An aqueous solution suitable for dissipating, at a controlled rate, available iodine contained in an iodophor is disclosed. The aqueous dissipating solution contains sorbic acid or soluble salts thereof and ethylenediaminetetraacetic acid or soluble salts thereof. Preferably, the dissipating solution also contains an ammonium, alkali metal, or alkaline earth metal salt of a boron oxyacid. Also disclosed are techniques for sterilizing contact lenses and sterile solutions, suitable for maintaining sterility of a previously sterilized object, comprising admixtures of the dissipating solutions with iodophor solutions.
187	Iodine composition and dissipating solution	US31579372	1972-12-18	US3911107A	1975-10-07	KREZANOSKI JOSEPH Z
An aqueous, antiseptic, iodophor solution is provided containing iodine, a water soluble iodide salt or hydriotic acid, polyvinyl alcohol and boric acid. The iodophor solution may be employed to sterilize a broad range of animate and inanimate objects, including contact lenses. Additionally, the iodophor solution, or similar iodophor solutions which do not contain boric acid, may be employed in visual temperature sensing devices. The visual temperature sensing devices comprise a transparent vessel containing the iodophor solution. Also disclosed is an aqueous solution for dissipating, at a controlled rate, available iodine contained in an iodophor. The aqueous dissipating solution contains sorbic acid or soluble salts thereof and ethylenediaminetetraacetic acid or soluble salts thereof.
188	Sterilization of soft, hydrophilic acrylate and methacrylate copolymer materials	US44664374	1974-02-28	US3876768A	1975-04-08	BLANK IZHAK
Soft, hydrophilic acrylate and methacrylate copolymer materials are sterilized by immersing them in a solution containing small, but effective amounts of a material which releases active halogen in solution, but is non-damaging to the eye in concentrations effective for sterilization. A particularly effective material is chlorinated trisodium phosphate. The concentrataion of the sterilant material should be such that it releases halogen in amounts of from about 2 parts per million to 250 parts per million. The technique is particularly useful for sterilization of soft, hydrophilic acrylate and methacrylate contact lenses.
189	OPHTHALMIC COMPOSITIONS FOR THERAPEUTIC AND PROPHYLACTIC USES	PCT/US2018/016696	2018-02-02	WO2018144909A1	2018-08-09	ROY, Chad; METZINGER, Rebecca
Disclosed herein are topical ophthalmic compositions comprising ammonium chloride, a quaternary ammonium salt, and stabilized chlorine dioxide. Also disclosed herein are methods of treating or preventing active infections of the tissues comprising the eye and surrounding parenchyma from bacterial, fungal, mycobacterial, mycoplasmal, viral, and protozoan amoeba microorganisms.
190	眼科組成物	PCT/JP2016/083944	2016-11-16	WO2017094508A1	2017-06-08	林　紗衣子; 辻　和宏; 清宮　暁
本発明は、（Ａ）アルギニン、２－アミノ－２－メチル－１，３－プロパンジオール、トリス（ヒドロキシメチル）アミノメタン、２－アミノエタノール及びこれらの塩からなる群より選択される１種以上と、（Ｂ）多糖類と、を含有する、眼科組成物に関する。
191	ELECTROCHEMICAL SYSTEM FOR DISINFECTING AND CLEANING CONTACT LENSES	PCT/US2015/021950	2015-03-23	WO2015153161A1	2015-10-08	TUCKER, Robert, Carey
The present invention is generally related to a lens care system and method for disinfecting and cleaning contact lenses. A lens care system or method of the invention is based on electrolysis of an aqueous chloride solution for generating germicide species (e.g., chlorine, hypochlorous acid, hypochlorite, or combinations thereof) and subsequent in-situ electrolysis of hypochlorous acid or hypochlorite in the aqueous solution for neutralizing the generated germicide species.
192	PHARMACEUTICAL COMPOSITION CONTAINING AN ELECTROCHEMICALLY ACTIVATED SALT SOLUTION	PCT/EP2011004470	2011-09-06	WO2012034659A3	2012-06-07	MATHE HANS-GEORG
The aim of the invention is to provide a pharmaceutical composition containing an active ingredient and a carrier substance, wherein the carrier substance comprises an electrochemically activated aqueous sodium chloride solution and is present in a phase separated from the active ingredient, wherein said pharmaceutical composition guarantees an especially long storage life and especially high long-term stability of the composition without unacceptable impairment of the effectiveness of the active ingredient. For this purpose, the carrier substance has a content of free chlorine of more than 500 mg/l, preferably of more than 600 mg/l, according to the invention.
193	L-HISTIDINE IN OPHTHALMIC SOLUTIONS	PCT/US0146762	2001-11-08	WO0238077A2	2002-05-16	SMITH FRANCIS XAVIER
The invention relates to an aqueous ophthalmic solution comprising 0.01 to about 1.0 percent by weight L-histidine; 0.01 to 0.0001 percent by weight hydrogen peroxide; 0.1 to 500 parts per million of a cationic polymeric preservative that provides superior preservative efficacy especially as against fungal microbes. These solutions may be employed in various ways including cleaning contact lenses, rinsing lenses while in the eye, storing lenses and in delivering active pharmaceutical agents to the eye.
194	MICROBIAL INHIBITORY COMPOSITIONS	PCT/AU2001/000295	2001-03-16	WO01068090A1	2001-09-20
The present invention provides an antimicrobial composition. The composition comprises a cell-permeabilising agent and at least one compound of general formula (I) wherein R1 and R2 are independently H, halogen, alkyl, alkoxy, oxoalkyl, alkenyl, aryl or arylalkyl whether unsubstituted or substituted, optionally interrupted by one or more heteroatoms, straight chain or branched chain, hydrophilic or fluorophilic; R3 and R4 are independently H, halogen, alkyl, aryl or arylalkyl, alkoxy; R3 or R4 + R2 can be a saturated or an unsaturated cycloalkane; and "-----" represents a single bond or a double bond provided that at least one of R1, R2, R3 and R4 is halogen.
195	CONTACT LENS CLEANER, AND PROTEIN REMOVAL AND STERILIZATION METHOD BY MEANS OF ELECTROPHORESIS DISSOCIATION	EP21851272.1	2021-07-29	EP4187312A1	2023-05-31	SUN, Bixia
A contact lens cleaner and a method for protein removal and sterilization by electrophoresis dissociation are disclosed. The contact lens cleaner comprises a lens cleaning tank (10), two electrophoresis dissociation probes (20) are arranged in the lens cleaning tank (10) opposite each other, and the electrophoresis dissociation probes (20) are electrically connected to a circuit power supply. The lens cleaning tank (10) is filled with an electrolyte solution; a lens to be cleaned is placed in the lens cleaning tank (10); and a switch is turned on, and the two electrophoresis dissociation probes (20) in the lens cleaning tank (10) form an anode and a cathode. There are lacrimal proteins on the surface of the lens to be cleaned, the lacrimal proteins are charged in the solution, and the charged lacrimal proteins move to the electrode opposite to the electrical property thereof in the cleaning tank (10) according to the phenomenon of electrophoresis. The electrolyte solution reacts chemically in the cleaning tank (10) to produce hypochlorite having a strong oxidizing property, and the hypochlorite can degrade the lacrimal proteins, and also can sterilize and disinfect.
196	Improved ophthalmic and contact lens solution	EP08014693.9	2001-11-08	EP1992340B1	2016-05-11	Smith, Francis, Xavier

197	Improved ophthalmic and contact lens solution	EP08014693.9	2001-11-08	EP1992340A1	2008-11-19	Smith, Francis, Xavier
The present invention relates to improved ophthalmic solutions that employ a preservative enhancer chosen from the group consisting of dexpanthenol and panthenol; and at least 0.00001 weight percent of a preservative, in order to more effectively preserve solutions and to reduce the degree to which cationic preservatives will deposit on contact lenses. Ophthalmic solutions are here understood to include contact lens treatment solutions, such as cleaners, soaking solutions, conditioning solutions and lens storage solutions, as well as wetting solutions and in-eye solutions for treatment of eye conditions. More particularly, a preferred ophthalmic solution comprises dexpanthenol, 0.2% of a phosphate buffer or Bis-Tris propane, and 0.00001 % of polyhexamethylene biguanide, wherein the solution is made isotonic with sodium chloride.
198	Contact lens care composition	EP06704705.0	2006-02-20	EP1850888B1	2008-09-17	Obwaller, Andreas
The present invention relates to ophthalmic compositions such as contact lens care solutions, containing miltefosine. The present invention further relates to ophthalmic compositions or contact lens care systems containing miltefosine in combination with additional other active microbiocidal substances or proteases. Furthermore, the invention relates to the use of the compositions for the removal and eradication of protozoan parasites such as Acanthamoeba from contact lenses.
199	Verwendung von Taurolidin und seiner Metaboliten als antimikrobieller Zusatz in Zubereitungen zur Behandlung, Reinigung, Aufbewahrung und zum Konditionieren von Kontaktlinsen	EP04010102.4	2004-04-28	EP1495772A1	2005-01-12	HERDEIS, Claus; Weis, Christian Edwin
Die Erfindung betrifft die Verwendung von Taurolidin und seinen Metaboliten wie insbesondere Taurultam als antimikrobieller Zusatz zu Lösungen zur Behandlung, Reinigung, Aufbewahrung und zum Conditioning von Kontaktlinsen.
200	MICROBIAL INHIBITORY COMPOSITIONS	EP01911289.5	2001-03-16	EP1274420A1	2003-01-15	HOLMSTROM, Gerd, Pia, Carola; KJELLEBERG, Staffan
The present invention provides an antimicrobial composition. The composition comprises a cell-permeabilising agent and at least one compound of general formula (I) wherein R1 and R2 are independently H, halogen, alkyl, alkoxy, oxoalkyl, alkenyl, aryl or arylalkyl whether unsubstituted or substituted, optionally interrupted by one or more heteroatoms, straight chain or branched chain, hydrophilic or fluorophilic; R3 and R4 are independently H, halogen, alkyl, aryl or arylalkyl, alkoxy; R3 or R4 + R2 can be a saturated or an unsaturated cycloalkane; and '-----' represents a single bond or a double bond provided that at least one of R1, R2, R3 and R4 is halogen.

5 6 7 8 9 10 11 12 13 14

IPRDB

热门服务

关于我们

友情链接

联系方式